entertainment -WSS

entertainment

author：fashion 2025-09-28 13:23:43 - browse：7

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Diversify hospital leadership teams to protect BIPOC patient health

entertainment

WSS

UCSF medical school apologizes for unethical prisoner experiments

Will General Catalyst be the first of many hospital takeovers?

STAT Executive Editor Rick Berke on STAT's 8th birthday

SAMSHA loosens regulations on methadone treatment centers

Study: New antibiotic targets gonorrhea as well as last existing drug

Sanofi CEO defends move to abandon profit guidance, boost research

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Will General Catalyst be the first of many hospital takeovers?

What does generative AI mean for health care? We asked experts

MoonLake credibility takes another hit with mid

Jerome Adams on the need for new antivirals for Covid

MoonLake credibility takes another hit with mid

ChatGPT in medicine: STAT answers readers' burning questions

Free speech concerns arise in wake of journal editor Eisen's firing

Psychedelics group wrestles with new pharma identity

Some dementia cases could be undiagnosed liver disease

entertainment

More doctors should go into startup world

STAT Executive Editor Rick Berke on STAT's 8th birthday

Even great ERs can’t make up for American health disparities

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Time to name cancers by genetics, not organ of origin, expert says

Extreme heat events are a public health emergency

entertainment

focus

entertainment

focus